Imeka Solutions
Entreprise d'imagerie cérébrale avancée qui fournit des biomarqueurs de la matière blanche pour la recherche clinique.
Les signaux additionnels (documents, emplois, communiqués, contacts…) sont des bonus : leur absence est normale selon le type d'organisation et ne réduit pas la visibilité.
7 signaux
ImekaTM receives FDA 510(k) clearance for ANDI 2.0
<p>November 1st, 2025—Imeka, the leading neuroimaging company combining diffusion imaging and AI to map white matter microstructure, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its new and improved flagship software – ANDI 2.0, adding brain volumetric analysis to its capabilities. Brain microstructure now adds macrostructure in a … <a href="https://imeka.ca/imekatm-receives-fda-510k-clearance-for-andi-2-0/">Continued</a></p> <p>The post <a href="https://imeka.ca/imekatm-receives-fda-510k-clearance-for-andi-2-0/">Imeka<sup>TM</sup> receives FDA 510(k) clearance for ANDI 2.0</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
Imeka at RSNA 2025 – Visit booth #5644
<p>We’ll be showcasing our flagship product – ANDI – at this year’s RSNA in Chicago, at McCormick Place, in the south Hall! We are very excited to showcase ANDI 2.0 during this years event, adding brain volumetry to ANDI’s capabilities.</p> <p>The post <a href="https://imeka.ca/imeka-at-rsna-2025-visit-booth-5644/">Imeka at RSNA 2025 – Visit booth #5644</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
We’ll be at this year’s ASNR!
<p>You can meet us at ASNR in Philadelphia, May 17-21 2025, to discuss quantitative MRI and introduce our new and advanced technology— ANDI.</p> <p>The post <a href="https://imeka.ca/well-be-at-this-years-rsna/">We’ll be at this year’s ASNR!</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
Imeka’s technology featured in new publication
<p>An independent article titled “Predicting recovery in patients with mild traumatic brain injury and a normal CT using serum biomarkers and diffusion tensor imaging (CENTER-TBI): an observational cohort study” was recently published in eClinicalMedicine, part of The Lancet Discovery Science.</p> <p>The post <a href="https://imeka.ca/imekas-technology-featured-in-new-publication/">Imeka’s technology featured in new publication</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
ImekaTM receives FDA 510(k) clearance for ANDI medical device
<p>July 31, 2023—Imeka, the leading neuroimaging company combining diffusion imaging and AI to map white matter microstructure, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Advanced Neuro Diagnostic Imaging (ANDI) quantitative imaging software.</p> <p>The post <a href="https://imeka.ca/imeka-receives-fda-510k-clearance-for-andi-medical-device/">Imeka<sup>TM</sup> receives FDA 510(k) clearance for ANDI medical device</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
ImekaTM and GE Healthcare collaborate to advance precision medicine for brain health
<p>April 5, 2022—GE Healthcare will integrate Imeka’s non-invasive neuroimaging technology into the BrainWave advanced diffusion processing package to allow researchers and clinicians to analyze diffusion MRI signals in the brain in greater detail.</p> <p>The post <a href="https://imeka.ca/imeka-and-ge-healthcare-collaborate-to-advance-precision-medicine-for-brain-health/">Imeka<sup>TM</sup> and GE Healthcare collaborate to advance precision medicine for brain health</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
ANDITM featured in new publication
<p>An independent scientific article about ANDI has been published in BMC Neurology by Dr. Cyrus Raji and his team from the Washington School of Medicine.</p> <p>The post <a href="https://imeka.ca/andi-featured-in-new-publication/">ANDI<sup>TM</sup> featured in new publication</a> appeared first on <a href="https://imeka.ca">Imeka</a>.</p>
Vous représentez Imeka ?
Revendiquez cette fiche pour contrôler les données publiées et devenir la source officielle consultée par les agents IA.
Revendiquer cette fiche →